The Small Intestine, an Underestimated Site of SARS-CoV-2 Infection: From Red Queen Effect to Probiotics
Explore this paper's citation graph
Summary
It is demonstrated here that enterocytes act as a conserved cell reservoir for coronaviruses during their evolutions, which should not be ignored in the investigation of coronavirus diagnosis and treatment strategies.
- Type
- preprint
- Published
- 2020-03-10
- Cited by
- 50
- References
- 20
- Access
- Open access
- OpenAlex
- https://openalex.org/W3012129487
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:216383043
Keywords
Coronavirus, Biology, Receptor, Middle East respiratory syndrome coronavirus, Angiotensin-converting enzyme 2
References
- Virions at the Gates: Receptors and the Host–Virus Arms Race
- Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in‐situ hybridization study of fatal cases
- Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells
- Running with the Red Queen: Host-parasite coevolution selects for biparental sex
- Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor
- Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
- MERS, SARS and other coronaviruses as causes of pneumonia
- A single-cell survey of the small intestinal epithelium
- Mapping the Mouse Cell Atlas by Microwell-Seq.
- Probiotics L. acidophilus and B. clausii Modulate Gut Microbiota in Th1- and Th2-Biased Mice to Ameliorate Salmonella Typhimurium-Induced Diarrhea
- Single-Cell Analysis of Crohn’s Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy
- Segmented filamentous bacteria prevent and cure rotavirus infection
- The human coronavirus HCoV-229E S-protein structure and receptor binding
- Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation
- Diarrhea may be underestimated: a missing link in 2019 novel coronavirus
- Evidence for Gastrointestinal Infection of SARS-CoV-2
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
- Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies
- Receptor recognition by novel coronavirus from Wuhan: 2 An analysis based on decade-long structural studies of SARS 3
Cited by
- Lung microbiota in the acute respiratory disease: from coronavirus to metabolomics
- Probiotics and COVID-19: one size does not fit all
- Emerging details about COVID-19 and chronology of the pandemic in Turkey
- ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors
- Probiotics and COVID‐19: is there any link?
- Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19
- Role of probiotics to combat viral infections with emphasis on COVID-19
- Prise en charge nutritionnelle des patients de réanimation ayant une infection au SARS-CoV-2
- Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route
- Glycyrrhizin: An old weapon against a novel coronavirus
- SARS-CoV-2 infection and the gut-liver axis.
- Investigating the human protein-host protein interactome of SARS-CoV-2 infection in the small intestine
- Gastrointestinal Symptoms and Immune Response in COVID 19 - Review of a Cat and Mouse Game Theory
- Novel and Controversial Therapies in COVID-19
- SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role
- Pathophysiological mechanisms of liver injury in COVID‐19
- Dual and mutual interaction between microbiota and viral infections: a possible treat for COVID-19
- Role of gut-lung microbiome crosstalk in COVID-19
- Profiling of Oral Microbiota and Cytokines in COVID-19 Patients
- Role of dietary supplement in viral infection with an outlook on corona virus disease-2019
Related papers
- Current status of treatment for 2019 novel coronavirus pneumonia
- Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus
- A novel human coronavirus: Middle East respiratory syndrome human coronavirus
- Research progress of novel Coronavirus pneumonia
- Coronavirus infection of children
- Broad-Spectrum Coronavirus Fusion Inhibitors to Combat COVID-19 and Other Emerging Coronavirus Diseases